BioSpace News Archive

Top-line avapritinib data support planned NDA for PDGFRA Exon 18 mutant GIST and fourth-line GIST in first half 2019

Sangamo Therapeutics, Inc. announced that Sandy Macrae, CEO of Sangamo, will present a corporate overview at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9th at 11:30 a.m. PT in San Francisco

Generation Bio announced the company will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 8, 2019

Sangamo Therapeutics, Inc. announced that interim clinical data from the Company’s inherited metabolic diseases development programs will be presented at WORLDSymposium, an annual conference dedicated to lysosomal diseases being held February 4-8th, 2019 at the Hyatt Regency Orlando in Orlando, Florida

Recursion, a clinical-stage biotechnology company combining artificial intelligence (AI), experimental biology, and automation to discover and develop drugs at scale, today announced it has entered into a licensing agreement with the Ohio State Innovation Foundation (OSIF

Agreement with FDA on Clinical Endpoints and Regulatory Path for Approval

SynAffix B.V. announced it has entered into a license agreement with Mersana Therapeutics, Inc.

Korn Ferry announced that Kim Crowley has joined the firm as senior client partner and global account leader in the Life Sciences market

AmpliPhi Biosciences Corporation and C3J Therapeutics, Inc. (“C3J”), a private clinical stage biotechnology company focused on the development of novel targeted antimicrobials, today announced that the companies have entered into a definitive agreement under which a wholly owned subsidiary of AmpliPhi will merge with C3J

The global ureteral dilators market 2019-2023 is expected to post a CAGR of close to 6% during the forecast period, according to the latest market research report by Technavio.